Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that Mr. Chen Qiyu resigned as Chairman and Authorised Representative with effect from 29 October 2020; Mr. Yao Fang resigned as co-chairman with effect from 29 October 2020; Mr. Wu Yifang has been elected as Chairman of the eighth session of the Board and Mr. Wu Yifang has been appointed as the Authorised Representative with effect from 29 October 2020; Mr. Chen Qiyu and Mr. Yao Fang will be re-designated from executive Directors to non-executive Directors with effect from 29 October 2020; and Mr. Wu Yifang resigned as president of the Company; Mr. Chen Yuqing, Mr. Wang Kexin and Mr. Li Dongming were appointed as the co-president of the Company and Ms. Guan Xiaohui was appointed as the executive president and the chief financial officer of the Company, such resignation and appointments shall take effect from 29 October 2020. Mr. Wu, born in April 1969, joined the Group in April 2004, served as the senior vice president of the Company from July 2014 to January 2016, the senior vice president and chief operating officer of the Company from January 2016 to June 2016, the president of the Company from June 2016 to October 2020, an executive Director since August 2016 and the chief executive officer of the Company (the ``CEO'') since June 2016, and serves as directors of several subsidiaries of the Company. Mr. Wu is currently the non-executive director of Sisram Medical Ltd. and Shanghai Henlius Biotech Inc., and the chairman of the supervisory committee of Sinopharm Group Co., Ltd., all of which are companies listed on the Hong Kong Stock Exchange. Mr. Wu worked as a technician, director, production officer, finance director, assistant to factory director of Xuzhou Biochemical Pharmaceutical Factory, a deputy factory director of Xuzhou (Wanbang) Biochemical Pharmaceutical Manufactures Factory, a deputy general manager of Xuzhou Wanbang Biochemical Pharmaceutical Co., Ltd. and Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd., president of Jiangsu Wanbang Biochemical (where Xuzhou Biochemical, Xuzhou (Wanbang) Biochemical, Xuzhou Wanbang Biochemical and Jiangsu Wanbang Biochemical were predecessors of Jiangsu Wanbang (Group) Biochemical Pharmaceutical Co., Ltd.), and the chairman of Jiangsu Wanbang Biochemical Pharmaceutical Co., Ltd. Mr. Wu graduated from Nanjing University of Science and Technology majoring in international trade in 1996 and obtained a master degree in business administration from Saint Joseph's University in 2005.